Cardioprotective effects and mechanism of Radix Salviae miltiorrhizae and Lignum Dalbergiae odoriferae on rat myocardial ischemia/reperfusion injury

Mu,Fei; Duan,Jialin; Bian,Haixu; Yin,Ying; Zhu,Yanrong; Wei,Guo; Guan,Yue; Wang,Yanhua; Guo,Chao; Wen,Aidong; Yang,Yong; Xi,Miaomiao

doi:10.3892/mmr.2017.6821

Cardioprotective effects and mechanism of Radix Salviae miltiorrhizae and Lignum Dalbergiae odoriferae on rat myocardial ischemia/reperfusion injury

Authors:
- Fei Mu
- Jialin Duan
- Haixu Bian
- Ying Yin
- Yanrong Zhu
- Guo Wei
- Yue Guan
- Yanhua Wang
- Chao Guo
- Aidong Wen
- Yong Yang
- Miaomiao Xi
View Affiliations

Affiliations: Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Department of Pharmacy, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, P.R. China
Published online on: June 20, 2017 https://doi.org/10.3892/mmr.2017.6821
Pages: 1759-1770
Copyright: © Mu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Radix Salviae miltiorrhizae (SM) and Lignum Dalbergiae odoriferae (DO) are traditional Chinese medicinal herbs used to treat ischemic heart disease and other cardiovascular diseases; however, to the best of our knowledge, there are currently few studies regarding their effects. The present study aimed to investigate the cardioprotective effects of SM and DO during myocardial ischemia/reperfusion (MI/R) injury in rats, and explore the molecular mechanisms that underlie their actions. In the present study, Sprague‑Dawley rats were pretreated with SM, the aqueous extract of DO (DOA) and the volatile oil of DO (DOO), either as a monotherapy or in combination for 7 days. Subsequently, the rats were subjected to 30 min of ischemia followed by 180 min of reperfusion. Traditional pharmacodynamic evaluation and metabonomics based on gas chromatography/time‑of‑flight mass spectrometry were used to identify the therapeutic effects of these traditional Chinese medicines. The results revealed that SM, DOA and DOO monotherapies ameliorated cardiac function, and this effect was strengthened further when used in combined therapies. Among the combined treatments, SM + DOO exhibited the greatest potential (P<0.05) to improve electrocardiogram results and heart rate, reduce the heart weight index and myocardial infarct size, and decrease the levels of creatine kinase‑MB and lactate dehydrogenase. In addition, metabonomics‑based findings, including the principal component analysis and partial least squares discriminant analysis score plot of the metabolic state in rat serum, provided confirmation for the aforementioned results, verifying that SM + DOO exerted synergistic therapeutic efficacies to exhibit a greater effect on rats with MI/R injury when compared with the other pretreatment groups. Furthermore, the most effective duration of SM + DOO treatment was 30 min and the least effective duration was 180 min. Treatment with SM + DOO also significantly (P<0.01) reduced the number of terminal deoxynucleotidyl transferase‑mediated dUTP nick end‑labeling‑positive cells, tumor necrosis factor‑α andinterleukin‑6 expression, and malondialdehyde content, and increased the serum and tissue activity of superoxide dismutase. These results indicated that the combined effects of SM + DOO may be more effective compared with the single pretreatments against MI/R injury in rats. This effect may be achieved partly through anti‑apoptotic, antioxidant and anti‑inflammatory activities. Therefore, SM + DOO may be considered an effective and promising novel strategy for the prophylaxis and treatment of ischemic heart disease.

View Figures

View References

1	Forman MB and Jackson EK: Myocardial reperfusion injury. N Engl J Med. 357:2408–2410. 2007. View Article : Google Scholar : PubMed/NCBI
2	Sivaraman V and Yellon DM: Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury. J Cardiovasc Pharmacol Ther. 19:83–96. 2014. View Article : Google Scholar : PubMed/NCBI
3	Monassier JP: Reperfusion injury in acute myocardial infarction. From bench to cath lab. Part I: Basic considerations. Arch Cardiovasc Dis. 101:491–500. 2008. View Article : Google Scholar : PubMed/NCBI
4	Rodriguez-Porcel M, Zhu XY, Chade AR, Amores-Arriaga B, Caplice NM, Ritman EL, Lerman A and Lerman LO: Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension. Am J Physiol Heart Circ Physiol. 290:H978–H984. 2006. View Article : Google Scholar : PubMed/NCBI
5	Liu H, Shang J, Chu F, Li A, Wu B, Xie X, Liu W, Yang H and Tong T: Protective effects of Shen-Yuan-Dan, a traditional Chinese medicine, against myocardial ischemia/reperfusion injury in vivo and in vitro. Evid Based Complement Alternat Med. 2013:9563972013. View Article : Google Scholar : PubMed/NCBI
6	Lakshmi SV, Padmaja G, Kuppusamy P and Kutala VK: Oxidative stress in cardiovascular disease. Indian J Biochem Biophys. 46:421–440. 2009.PubMed/NCBI
7	Gottlieb RA: Cell death pathways in acute ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther. 16:233–238. 2011. View Article : Google Scholar : PubMed/NCBI
8	Koenitzer JR and Freeman BA: Redox signaling in inflammation: Interactions of endogenous electrophiles and mitochondria in cardiovascular disease. Ann NY Acad Sci. 1203:45–52. 2010. View Article : Google Scholar : PubMed/NCBI
9	Li J, Zhang H and Zhang C: Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: Mechanisms and therapeutic implications. J Mol Cell Cardiol. 52:865–872. 2012. View Article : Google Scholar : PubMed/NCBI
10	Guan Y, Yin Y, Zhu YR, Guo C, Wei G, Duan JL, Wang YH, Zhou D, Quan W, Weng Y, et al: Dissection of mechanisms of a Chinese medicinal formula: Danhong injection therapy for myocardial ischemia/reperfusion injury in vivo and in vitro. Evid Based Complement Alternat Med. 2013:9723702013. View Article : Google Scholar : PubMed/NCBI
11	Zhao N, Liu YY, Wang F, Hu BH, Sun K, Chang X, Pan CS, Fan JY, Wei XH, Li X, et al: Cardiotonic pills, a compound Chinese medicine, protects ischemia-reperfusion-induced microcirculatory disturbance and myocardial damage in rats. Am J Physiol Heart Circ Physiol. 298:H1166–H1176. 2010. View Article : Google Scholar : PubMed/NCBI
12	Liu Q, Li J, Wang J, Li J, Janicki JS and Fan D: Effects and mechanisms of Chinese herbal medicine in ameliorating myocardial ischemia-reperfusion injury. Evid Based Complement Alternat Med. 2013:9256252013. View Article : Google Scholar : PubMed/NCBI
13	Geng Z, Huang L, Song M and Song Y: Protective effect of a polysaccharide from Salvia miltiorrhiza on isoproterenol (ISO)-induced myocardial injury in rats. Carbohyd Polym. 132:638–642. 2015. View Article : Google Scholar
14	Sugiyama A, Zhu BM, Takahara A, Satoh Y and Hashimoto K: Cardiac effects of Salvia miltiorrhiza/Dalbergia odorifera mixture, an intravenously applicable Chinese medicine widely used for patients with ischemic heart disease in China. Circ J. 66:182–184. 2002. View Article : Google Scholar : PubMed/NCBI
15	Zhao L, Gao H, Zhao Y and Lin D: Metabonomic analysis of the therapeutic effect of Zhibai Dihuang pill in treatment of streptozotocin-induced diabetic nephropathy. J Ethnopharmacol. 142:647–656. 2012. View Article : Google Scholar : PubMed/NCBI
16	Liu P and Wang P: Application of metabolomics technology in the research of Chinese medicine. Chin J Integr Med. 20:307–310. 2014. View Article : Google Scholar : PubMed/NCBI
17	Chen M, Su M, Zhao L, Jiang J, Liu P, Cheng J, Lai Y, Liu Y and Jia W: Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. J Proteome Res. 5:995–1002. 2006. View Article : Google Scholar : PubMed/NCBI
18	Griffin JL and Bollard ME: Metabonomics: Its potential as a tool in toxicology for safety assessment and data integration. Curr Drug Metab. 5:389–398. 2004. View Article : Google Scholar : PubMed/NCBI
19	Yin P, Zhao X, Li Q, Wang J, Li J and Xu G: Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). J Proteome Res. 5:2135–2143. 2006. View Article : Google Scholar : PubMed/NCBI
20	Ganna A, Salihovic S, Sundstrüm J, Broeckling CD, Hedman AK, Magnusson PK, Pedersen NL, Larsson A, Siegbahn A, Zilmer M, et al: Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease. PLoS Genet. 10:e10048012014. View Article : Google Scholar : PubMed/NCBI
21	Luo L, Zhen L, Xu Y, Yang Y, Feng S, Wang S and Liang S: (1)H NMR-based metabonomics revealed protective effect of Naodesheng bioactive extract on ischemic stroke rats. J Ethnopharmacol. 186:257–269. 2016. View Article : Google Scholar : PubMed/NCBI
22	Chang KL and Ho PC: Gas chromatography time-of-flight mass spectrometry (GC-TOF-MS)-based metabolomics for comparison of caffeinated and decaffeinated coffee and its implications for Alzheimer's disease. PLoS One. 9:e1046212014. View Article : Google Scholar : PubMed/NCBI
23	Klein J, Papadopoulos T, Mischak H and Mullen W: Comparison of CE-MS/MS and LC-MS/MS sequencing demonstrates significant complementarity in natural peptide identification in human urine. Electrophoresis. 35:1060–1064. 2014. View Article : Google Scholar : PubMed/NCBI
24	Tang YM, Wang JP, Bao WM, Yang JH, Ma LK, Yang J, Chen H, Xu Y, Yang LH, Li W, et al: Urine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosis. Int J Mol Med. 36:377–385. 2015.PubMed/NCBI
25	Koek MM, Muilwijk B, van der Werf MJ and Hankemeier T: Microbial metabolomics with gas chromatography/mass spectrometry. Anal Chem. 78:1272–1281. 2006. View Article : Google Scholar : PubMed/NCBI
26	Wang SX, Luo K, Liang J, Fan F, Li H, Zheng JB and Zheng XH: Metabolomics study on the synergistic interaction between Salvia miltiorrhiza and Lignum Dalbergiae odoriferae used as ‘Jun-Shi’ herbs in a S. miltiorrhiza recipe. Med Chem Res. 20:16–22. 2011. View Article : Google Scholar
27	Liu R, Sun J, Bi K and Guo D: Identification and determination of major flavonoids in rat serum by HPLC-UV and HPLC-MS methods following oral administration of Dalbergia odorifera extract. J Chromatogr B Analyt Technol Biomed Life Sci. 829:35–44. 2005. View Article : Google Scholar : PubMed/NCBI
28	Yin Y, Guan Y, Duan J, Wei G, Zhu Y, Quan W, Guo C, Zhou D, Wang Y, Xi M and Wen A: Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation. Eur J Pharmacol. 699:219–226. 2013. View Article : Google Scholar : PubMed/NCBI
29	Zheng X, Zhao X, Wang S, Luo K, Wei Y and Zheng J: Co-administration of Dalbergia odorifera increased bioavailability of Salvia miltiorrhizae in rabbits. Am J Chin Med. 35:831–840. 2007. View Article : Google Scholar : PubMed/NCBI
30	Quan W, Wei G, Zhou D, Zhu Y, Guo C, Wang Y, Weng Y, Xi M and Wen A: Magnesium lithospermate B reduces myocardial ischemia/reperfusion injury in rats. Pharm Biol. 51:1355–1362. 2013. View Article : Google Scholar : PubMed/NCBI
31	Deng Y, Yang M, Xu F, Zhang Q, Zhao Q, Yu H, Li D, Zhang G, Lu A, Cho K, et al: Combined salvianolic acid B and ginsenoside Rg1 exerts cardioprotection against ischemia/reperfusion injury in rats. PLoS One. 10:e1354352015. View Article : Google Scholar
32	Arya DS, Bansal P, Ojha SK, Nandave M, Mohanty I and Gupta SK: Pyruvate provides cardioprotection in the experimental model of myocardial ischemic reperfusion injury. Life Sci. 79:38–44. 2006. View Article : Google Scholar : PubMed/NCBI
33	Kemp M, Donovan J, Higham H and Hooper J: Biochemical markers of myocardial injury. Br J Anaesth. 93:63–73. 2004. View Article : Google Scholar : PubMed/NCBI
34	Yan J, Duan J, Wu X, Guo C, Yin Y, Zhu Y, Hu T, Wei G, Wen A and Xi M: Total saponins from Aralia taibaiensis protect against myocardial ischemia/reperfusion injury through AMPK pathway. Int J Mol Med. 36:1538–1546. 2015.PubMed/NCBI
35	Tao Z, Chen B, Tan X, Zhao Y, Wang L, Zhu T, Cao K, Yang Z, Kan YW and Su H: Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proc Natl Acad Sci USA. 108:2064–2069. 2011. View Article : Google Scholar : PubMed/NCBI
36	Kung G, Konstantinidis K and Kitsis RN: Programmed necrosis, not apoptosis, in the heart. Circ Res. 1017–1036. 2011. View Article : Google Scholar : PubMed/NCBI
37	Garciarena CD, Fantinelli JC, Caldiz CI, de Cingolani G Chiappe, Ennis IL, Pérez NG, Cingolani HE and Mosca SM: Myocardial reperfusion injury: Reactive oxygen species vs. NHE-1 reactivation. Cell Physiol Biochem. 27:13–22. 2011. View Article : Google Scholar : PubMed/NCBI
38	Jaeschke H and Woolbright BL: Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species. Transplant Rev (Orlando). 26:103–114. 2012. View Article : Google Scholar : PubMed/NCBI
39	Zheng W, Huang LZ, Zhao L, Wang B, Xu HB, Wang GY, Wang ZL and Zhou H: Superoxide dismutase activity and malondialdehyde level in plasma and morphological evaluation of acute severe hemorrhagic shock in rats. Am J Emerg Med. 26:54–58. 2008. View Article : Google Scholar : PubMed/NCBI
40	Schettler V, Methe H, Staschinsky D, Schuff-Werner P, Müller GA and Wieland E: Review: The oxidant/antioxidant balance during regular low density lipoprotein apheresis. Ther Apher. 3:219–226. 1999. View Article : Google Scholar : PubMed/NCBI
41	Willerson JT and Ridker PM: Inflammation as a cardiovascular risk factor. Circulation. 109 21 Suppl 1:II2–II10. 2004. View Article : Google Scholar : PubMed/NCBI
42	Gasparyan AY: Cardiovascular risk and inflammation: Pathophysiological mechanisms, drug design, and targets. Curr Pharm Des. 18:1447–1449. 2012. View Article : Google Scholar : PubMed/NCBI
43	Song F, Li H, Sun J and Wang S: Protective effects of cinnamic acid and cinnamic aldehyde on isoproterenol-induced acute myocardial ischemia in rats. J Ethnopharmacol. 150:125–130. 2013. View Article : Google Scholar : PubMed/NCBI
44	Yan B, Deng Y, Hou J, Bi Q, Yang M, Jiang B, Liu X, Wu W and Guo D: UHPLC-LTQ-Orbitrap MS combined with spike-in method for plasma metabonomics analysis of acute myocardial ischemia rats and pretreatment effect of Danqi Tongmai tablet. Mol Biosyst. 11:486–496. 2015. View Article : Google Scholar : PubMed/NCBI
45	Fei M, Duan J and Xi M: GW27-e0912 cardioprotective effects of Radix Salviae miltiorrhizae and Lignum Dalbergiae odoriferae on rat myocardial ischemia/reperfusion injury. J Am Coll Cardiol. Suppl S 68:C642016. View Article : Google Scholar